Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups. J Thromb Haemost. 2013 Mar; 11(3):444-51.
View in:
PubMed
subject areas
Administration, Oral
Administration, Oral
Age Factors
Age Factors
Aged
Aged
Anticoagulants
Anticoagulants
Arthroplasty, Replacement, Hip
Arthroplasty, Replacement, Hip
Arthroplasty, Replacement, Knee
Arthroplasty, Replacement, Knee
Biomarkers
Biomarkers
Body Mass Index
Body Mass Index
Body Weight
Body Weight
Chi-Square Distribution
Chi-Square Distribution
Clinical Trials, Phase III as Topic
Clinical Trials, Phase III as Topic
Creatinine
Creatinine
Drug Administration Schedule
Drug Administration Schedule
Enoxaparin
Enoxaparin
Female
Female
Fibrinolytic Agents
Fibrinolytic Agents
Hemorrhage
Hemorrhage
Humans
Humans
Logistic Models
Logistic Models
Male
Male
Middle Aged
Middle Aged
Multivariate Analysis
Multivariate Analysis
Pyrazoles
Pyrazoles
Pyridones
Pyridones
Randomized Controlled Trials as Topic
Randomized Controlled Trials as Topic
Risk Assessment
Risk Assessment
Risk Factors
Risk Factors
Sex Factors
Sex Factors
Treatment Outcome
Treatment Outcome
Venous Thromboembolism
Venous Thromboembolism
authors with profiles
Gary E Raskob